SCHEMBL30441378

SCHEMBL30441378

CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CC5(CC(N)C5)C4)c3n2)COC1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 4/20 0.80
IRAK4 Q9NWZ3 2/20 0.80
GAK O14976 1/20 0.80
RIPK2 O43353 1/20 0.80
ULK1 O75385 1/20 0.80
STK10 O94804 1/20 0.80
PRKD3 O94806 1/20 0.80
MAP4K4 O95819 1/20 0.80
LATS1 O95835 1/20 0.80
PAK4 O96013 1/20 0.80
NTRK1 P04629 1/20 0.80
LCK P06239 1/20 0.80
CDK1 P06493 1/20 0.80
APRT P07741 1/20 0.80
RET P07949 1/20 0.80
PDGFRB P09619 1/20 0.80
PHKG2 P15735 1/20 0.80
NQO2 P16083 1/20 0.80
PDGFRA P16234 1/20 0.80
FECH P22830 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27030775 1.00 FLT3 (0.80) FLT3IRAK4GAKRIPK2ULK1
SCHEMBL27030604 0.90 FLT3 (0.85) FLT3IRAK4GAKRIPK2ULK1
SCHEMBL30775111 0.90 FLT3 (0.85) FLT3IRAK4GAKRIPK2ULK1
Crenolanib SCHEMBL30002138 0.89 FLT3 (1.00) FLT3IRAK4GAKRIPK2ULK1
Crenolanib SCHEMBL29350134 0.89 FLT3 (1.00) FLT3IRAK4GAKRIPK2ULK1
Crenolanib SCHEMBL2730601 0.89 FLT3 (1.00) FLT3IRAK4GAKRIPK2ULK1
Crenolanib SCHEMBL29352568 0.89 FLT3 (1.00) FLT3IRAK4GAKRIPK2ULK1
SCHEMBL25290500 0.88 IRAK4 (0.66) FLT3IRAK4GAKRIPK2ULK1
SCHEMBL29450889 0.88 IRAK4 (0.66) FLT3IRAK4GAKRIPK2ULK1
SCHEMBL22567082 0.85 IRAK4 (0.86) FLT3IRAK4GAKRIPK2ULK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024233967-A2 SIK INHIBITORS TO TREAT CHRONIC KIDNEY DISEASE THE GENERAL HOSPITAL CORPORATION (US) 2024-11-14 WO disclosed
CN-116234549-A Salt-induced kinase inhibitors 总医院公司 2023-06-06 CN disclosed